Recent News

By Category: Countermeasures

U.S. Army Supplies Upgraded WMD Protection Suits to Forces in South Korea

(Global Security Newswire) The U.S. Army on Monday said it has provided a South Korea-based unit with new chemical- and biological-weapon protection suits incorporating updated technology. The Army’s 2nd Combat Aviation Brigade was selected to receive the new Joint Protective Aircrew Ensemble system in October “from a priority list … that considers the magnitude of Read More »

December 21, 2011
| Filed under Asia/Pacific, North America, Countermeasures, International, and Policy & Initiatives
Share

India Seeks Remote-Controlled Robot for WMD Monitoring

(Global Security Newswire) India’s Defense Research and Development Organization has undertaken a $94.8 million effort to develop remote-controlled robots for various missions, including monitoring of WMD agents, the Times of India reported on Tuesday. “We are in discussion with the army to finalize the UGV [unmanned ground vehicle] program soon,” S. Sundaresh, DRDO chief controller Read More »

December 21, 2011
| Filed under South Asia, Countermeasures, and Policy & Initiatives
Share

Universal Detection Technology Announces Sale of Biological Weapon Detection ..

(MarketWatch) “We are very pleased to supply our armed forces with the tools to detect agents of Bioterror such as Anthrax and Ricin,” said Mr. Jacques Tizabi, UNDT Chairman and CEO. “We understand that, unfortunately, the threat posed by Biological weapons is …

December 19, 2011
| Filed under North America, Biological Weapons, and Countermeasures
Share

Soligenix, Harvard University commence anthrax vaccine development

(Pharmaceutical Business Review) Soligenix, a biopharmaceutical company, has commenced a next generation anthrax vaccine development project under the agreement with Harvard University. The company entered a field-exclusive option agreement with Harvard University to negotiate a …

December 19, 2011
| Filed under North America, Countermeasures, and Research
Share

US cell-based flu vaccine plant open for business

(Nature News Blog) Americans may soon be getting flu jabs made with cells and not eggs. The drug company Novartis opened a first-of-its kind facility in the US to produce influenza vaccines using mammalian cells, Novartis and US government officials announced 13 December. The approach is an alternative to conventional vaccine manufacturing, which relies on Read More »